Ting Chen

Ting Chen


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
JLJiatong Li
Jiatong Li
YBYang Bai
Yang Bai
HZHe Zhang
He Zhang
TCTing Chen
Ting Chen
GSGuanning Shang
Guanning Shang
Introduction: Osteosarcoma is a common type of bone cancer characterized by a poor prognosis due to its metastatic nature. The tumor microenvironment (TME) plays a critical role in tumor metastasis and therapy response. Therefore, our study aims to explore the metastatic mechanism of osteosarcoma, potentially opening new avenues for cancer treatment.Methods: In this study, we collected data from the GSE152048, GSE14359, and GSE49003 datasets. Differentially expressed genes (DEGs) were identified in osteosarcoma cases with primary and metastatic features using R software and the limma package. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed to investigate metastasis-related genes. A protein–protein interaction (PPI) network was established using the STRING database to further analyze these metastasis-associated genes. The abundances of different cell types with a mixed cell population were estimated using the CIBERSORT approach. The scRNA-seq data were analyzed by the Seurat package in R software, and intercellular communications were elucidated using the CellChat R package.Results: In this study, 92 DEGs related to metastasis were identified, including 41 upregulated and 51 downregulated genes in both the GSE14359 and GSE49003 datasets. Metastasis-associated pathways were identified, including those involving the cyclin-dependent protein kinase holoenzyme complex, transferase complex, transferring phosphorus-containing groups, SCF ubiquitin ligase complex, and the serine/threonine protein kinase complex. KEGG and PPI network analyses revealed 15 hub genes, including Skp2, KIF20A, CCNF, TROAP, PHB, CKS1B, MCM3, CCNA2, TRIP13, CENPM, Hsp90AB1, JUN, CKS2, TK1, and KIF4A. Skp2 has been known as an E3 ubiquitin ligase involved in osteosarcoma progression. The proportion of CD8+ T cells was found to be higher in metastatic osteosarcoma tissues, and high expression of PHB was associated with a favorable prognosis in osteosarcoma patients. Additionally, 23 cell clusters were classified into eight cell types, including chondrocytes, MSC, T cells, monocytes, tissue stem cells, neurons, endothelial cells, and macrophages. The 15 hub genes were expressed across various cell types, and interactions between different cell types were observed.Conclusion: Our study reveals the intricate communication between tumor microenvironment components and tumor metastasis in osteosarcoma.

16 March 2023 in Cancer Letters
Verified
Journal Article
Closed access
SLShizhe Li
Shizhe Li
TCTing Chen
Ting Chen
JLJinxin Liu
Jinxin Liu
HZHe Zhang
He Zhang
JLJiatong Li
Jiatong Li
GSGuanning Shang
Guanning Shang

18 September 2018 in Oncology Letters
Verified
Journal Article
Open access
PDF file
TCTing Chen
Ting Chen
YLYuyang Li
Yuyang Li
WCWenliang Cao
Wenliang Cao
JJJian Jiang
Jian Jiang
Increasing evidence has indicated that microRNAs (miRNAs/miRs) are associated with tumorigenesis and the development of numerous cancer types. Previous studies have suggested miRNA‑491‑5p is downregulated in osteosarcoma (OS) and functions as a tumor suppressor. However, the biological roles and underlying mechanisms associated with miR‑491‑5p function in OS require further exploration. In the present study, it was demonstrated by reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) that miR‑491‑5p was downregulated in 36 pairs of OS tissues, compared with in adjacent normal bone tissues. Furthermore, CCK‑8 and colony formation assays indicated that miR‑491‑5p mimics suppressed OS cell proliferation. However, an miR‑491‑5p inhibitor enhanced cell proliferation. In addition, luciferase reporter assays, RT‑qPCR and western blot analysis demonstrated that PKM2 was a direct target of miR‑491‑5p. The miR‑491‑5p mimic inhibited the mRNA and protein expression of PKM2, while the miR‑491‑5p inhibitor promoted PKM2 mRNA and protein expression. In addition, PKM2 overexpression reversed the proliferation‑inhibiting effects of miR‑491‑5p in OS cells. Therefore, these results indicated that miR‑491‑5p serves as a tumor suppressor in OS cells, which may be important in OS treatment.

17 August 2024 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
HZHe Zhang
He Zhang
YBYang Bai
Yang Bai
JLJiatong Li
Jiatong Li
TCTing Chen
Ting Chen
GSGuanning Shang
Guanning Shang
Accumulating evidence has demonstrated that F‐box protein 22 (FBXO22) participates in tumour development and progression in various types of human malignancies. However, the functions and detailed molecular mechanisms of FBXO22 in osteosarcoma tumorigenesis and progression remain elusive. In this study, we aimed to determine the effects of FBXO22 on the cell proliferation, migration and invasion of osteosarcoma cells using cell counting kit‐8 and Matrigel Transwell approaches. Moreover, we explored the molecular mechanisms by which FBXO22 mediated oncogenesis and progression in osteosarcoma via Western blotting, immunoprecipitation and ubiquitination. We found that FBXO22 depletion inhibited the proliferation, migration and invasion of osteosarcoma cells, whereas FBXO22 overexpression increased the proliferation and motility of osteosarcoma cells. Mechanistically, FBXO22 promoted the ubiquitination and degradation of FoxO1 in osteosarcoma cells. FBXO22 depletion reduced cell proliferation and motility via regulation of FoxO1. Taken together, our findings provide new insight into FBXO22‐induced osteosarcoma tumorigenesis. The inhibition of FBXO22 could be a promising strategy for the treatment of osteosarcoma.